| Bioactivity | AGI-134 is a fully synthetic alpha-Gal glycolipid. AGI-134 invokes CD8+ T cell-mediated immunity. AGI-134 induces tumor cell destruction and phagocytosis[1]. |
| Name | AGI-134 |
| CAS | 1821461-84-0 |
| Formula | C70H126N3O26P |
| Molar Mass | 1456.73 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Irit Carmi LEVY, et al. Agi-134 combined with a checkpoint inhibitor for the treatment of solid tumors. WO2019229745A1. 2019. [2]. Masaki Asada, et al. 3-(2-Aminocarbonylphenyl)propanoic acid analogs as potent and selective EP3 receptor antagonists. Part 3: Synthesis, metabolic stability, and biological evaluation of optically active analogs. Bioorg Med Chem. 2010, 18, 9. |
AGI-134
CAS: 1821461-84-0 F: C70H126N3O26P W: 1456.73
AGI-134 is a fully synthetic alpha-Gal glycolipid. AGI-134 invokes CD8+ T cell-mediated immunity.AGI-134 induces tumor c
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.